These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21692067)

  • 21. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer.
    Asiri IM; Chen RC; Young HN; Codling J; Mandawat A; Beach SRH; Master V; Rajbhandari-Thapa J; Cobran EK
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1093-1102. PubMed ID: 33941865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.
    Xu J; Janisse J; Ruterbusch J; Ager J; Schwartz KL
    J Racial Ethn Health Disparities; 2016 Mar; 3(1):35-45. PubMed ID: 26896103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Relative Importance of Race Compared to Health Care and Social Factors in Predicting Prostate Cancer Mortality: A Random Forest Approach.
    Hanson HA; Martin C; O'Neil B; Leiser CL; Mayer EN; Smith KR; Lowrance WT
    J Urol; 2019 Dec; 202(6):1209-1216. PubMed ID: 31246547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial variation in receipt of quality radiation therapy for prostate cancer.
    Lee DJ; Zhao Z; Huang LC; Koyoma T; Resnick MJ; Penson DF; Barocas DA; Hoffman KE
    Cancer Causes Control; 2018 Oct; 29(10):895-899. PubMed ID: 30099628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study.
    Abdollah F; Sammon JD; Majumder K; Reznor G; Gandaglia G; Sood A; Hevelone N; Kibel AS; Nguyen PL; Choueiri TK; Selvaggi KJ; Menon M; Trinh QD
    J Natl Compr Canc Netw; 2015 Sep; 13(9):1131-8. PubMed ID: 26358797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Race and Time to Receipt of Androgen Deprivation Therapy Among Men With Metastatic Prostate Cancer.
    Cobran EK; Young HN; Chen RC; Chen X; Reeves J; Godley PA; Shah S
    J Natl Med Assoc; 2019 Jun; 111(3):246-255. PubMed ID: 30389146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer.
    Hoge C; Verma S; Lama DJ; Bergelson I; Haj-Hamed M; Maynor S; Gaitonde K; Sidana A
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):567-572. PubMed ID: 32152436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population.
    Lichtensztajn DY; Leppert JT; Brooks JD; Shah SA; Sieh W; Chung BI; Gomez SL; Cheng I
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1353-1360. PubMed ID: 30442735
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
    Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
    JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study.
    Stokes WA; Hendrix LH; Royce TJ; Allen IM; Godley PA; Wang AZ; Chen RC
    Cancer; 2013 Jul; 119(13):2486-93. PubMed ID: 23716470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer.
    Moses KA; Orom H; Brasel A; Gaddy J; Underwood W
    Urol Oncol; 2016 Sep; 34(9):415.e7-415.e12. PubMed ID: 27161898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL
    J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
    Mahal AR; Mahal BA; Nguyen PL; Yu JB
    Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
    Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
    S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.
    Wong AT; Safdieh JJ; Rineer J; Weiner J; Schwartz D; Schreiber D
    Int Urol Nephrol; 2015 Oct; 47(10):1629-34. PubMed ID: 26329748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thirty-day readmission rates for Medicare beneficiaries by race and site of care.
    Joynt KE; Orav EJ; Jha AK
    JAMA; 2011 Feb; 305(7):675-81. PubMed ID: 21325183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.